GlassScriptPhysician profile
Christopher A Kearns
NPI 1396732806
$2,798.14
in general payments reported to CMS, 2019-2025
13 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $164 · 2021: $252 · 2022: $383 · 2023: $165 · 2024: $399 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,118.77 | 2021-2025 | Barrigel, Urolift |
| Calyxo, INC. | $323.81 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $283.93 | 2025 | |
| Neotract INC. | $254.04 | 2019-2020 | |
| Bioprotect Medical, INC. | $186.48 | 2024-2025 | Bioprotect Balloon Implant System |
| Urogen Pharma, INC. | $135.39 | 2024 | |
| Stryker Corporation | $128.51 | 2024 | Aim (Advanced Imaging Modality), Infinity, 1788 |
| Astellas Pharma US INC | $119.01 | 2019 | |
| Boston Scientific Corporation | $114.11 | 2019-2025 | General - Erectile Dysfunction |
| Pfizer INC. | $70.81 | 2019-2024 | |
| Urovant Sciences INC | $25.75 | 2022 | |
| Olympus America INC. | $21.53 | 2021 | |
| Metuchen Pharmaceuticals | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kearns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.